Clinical Research Directory
Browse clinical research sites, groups, and studies.
hepatomiR cACLD Study
Sponsor: Karl Landsteiner University of Health Sciences
Summary
This study looks to gather data on hepatomiR, a CE-certified test already intended for gauging liver-related outcomes, in order to define a cut-off regarding specific decompensation events (ascites, variceal hemorrhage, hepatic encephalopathy) in chronic liver disease (CLD). Based on these data, it is aimed to advance the current understanding of factors driving decompensation, with potential repercussions for future risk management and therapy.
Official title: Assessment of a hepatomiR Cut-off for Predicting Specific Hepatic Decompensation Events in Advanced Chronic Liver Disease
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
156
Start Date
2024-05-15
Completion Date
2026-06
Last Updated
2025-09-09
Healthy Volunteers
No
Interventions
hepatomiR
hepatomiR is a CE-certified test intended for gauging liver-related outcomes. It quantifies the levels of hsa-miR-122-5p, hsa-miR-192-5p, and hsa-miR-151a-5p in human plasma samples. A proprietary algorithm is then used to compute a liver function score (hepatomiR p-score).
Locations (1)
University Hospital St. Pölten
Sankt Pölten, Lower Austria, Austria